Remsima 100 mg
Remsima 100 mg is a medicine authorised by Swissmedic under authorisation number 70236. The authorisation holder is IQONE HEALTHCARE SWITZERLAND SA. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 03 July 2026 and the authorisation is limited until 02 July 2031. ATC code L04AB02 places the medicine in the group Immunosuppressants.
| Authorisation number | 70236 |
|---|---|
| Name | Remsima 100 mg |
| Full name | Remsima 100 mg, solution à diluer pour perfusion |
| Authorisation holder | IQONE HEALTHCARE SWITZERLAND SA |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L04AB02 |
| First authorisation | 03 July 2026 |
| Authorisation validity | 02 July 2031 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Remsima 100 mg, solution à diluer pour perfusion | A | 06 July 2026 |
| 2 | Remsima 350 mg, solution à diluer pour perfusion | A | 06 July 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L04AB02 | 07.15.0. | A |
| 2 | 1 | Durchstechflasche(n) | L04AB02 | 07.15.0. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Remsima 100 mg authorised in Switzerland?
Yes. Remsima 100 mg is authorised by Swissmedic under authorisation number 70236, data as of 01 September 2026. The authorisation is limited until 02 July 2031.
Which dispensing category does Remsima 100 mg have?
Remsima 100 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Remsima 100 mg?
The authorisation holder is IQONE HEALTHCARE SWITZERLAND SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.